Last updated: June 16, 2026
DYANAVEL XR (amphetamine) is supplied through a defined chain that typically includes (1) API manufacture, (2) formulation and long-range delivery technology processing, (3) fill-finish for the extended-release oral suspension, and (4) label and distribution logistics. However, no supplier list can be produced from the information provided here.
What companies supply the API for DYANAVEL XR?
A complete and accurate API supplier roster for DYANAVEL XR cannot be determined from the available input. Supplier identity is usually derived from FDA labeling/manufacturing sections, Drug Master Files, Orange Book manufacturing entries, and procurement disclosures. None of those data are present.
Which amphetamine API suppliers are listed on FDA labeling?
No FDA labeling manufacturing table or section text is provided, so the API manufacturing entities cannot be extracted.
What contract manufacturers make and fill DYANAVEL XR extended-release oral suspension?
A contract-manufacturing and fill-finish supplier map for DYANAVEL XR cannot be generated without access to product-specific manufacturing site listings (e.g., “Manufactured for/Distributed by,” “Distributed by,” and site addresses) and corresponding facility records. Those records are not included in the input.
Which dosage form and strength changes affect manufacturing?
No formulation strength or product configuration details are provided (e.g., bottle size, concentration, or approved strengths), so manufacturing differences by strength cannot be mapped.
What facilities supply DYANAVEL XR from long-range delivery production?
Long-range delivery oral suspension products generally require specialized processing steps. The actual facility set for DYANAVEL XR depends on the approved manufacturing sites for the product. Those site entries are not provided.
What is the Orange Book status of DYANAVEL XR and how does it tie to suppliers?
The Orange Book status (listed drug, applicants/holders, dosage form identifiers, and manufacturing information in listing records) is not provided. Without the listing record, supplier-linked entries cannot be established.
Who are the key upstream suppliers and licensors behind DYANAVEL XR manufacturing?
Key upstream contributors, including technology owners and processing licensors, require citation to product labeling acknowledgments, technical transfer documentation, or patent assignee-linked supply chain disclosures. None are included.
Which DYANAVEL XR competitors use the same type of supplier ecosystem?
A competitor-to-supplier comparison requires a supplier list for DYANAVEL XR and then matching manufacturing/fill-finish patterns across comparable extended-release amphetamine products. No supplier list is provided for DYANAVEL XR.
Key Takeaways
- A supplier list for DYANAVEL XR cannot be produced from the provided information.
- Supplying entities for API manufacture, formulation, and fill-finish require product-specific FDA labeling and/or Orange Book manufacturing listing records, which are not present in the input.
FAQs
- Which FDA documents list DYANAVEL XR manufacturing sites?
- How can Orange Book “applicant” entries identify DYANAVEL XR supply chain players?
- Do DYANAVEL XR strength-specific SKUs use different manufacturing sites?
- How do Drug Master Files (DMFs) map to DYANAVEL XR API suppliers?
- What data sources most reliably identify contract fill-finish vendors for oral extended-release suspensions?
References
No sources were provided in the input.
